oligometastatic prostate carcinoma
Showing 1 - 5 of 5
Oligometastatic Prostate Carcinoma Trial in China (ADT combined with abiraterone, neoadjuvant hormone and RT)
Not yet recruiting
- Oligometastatic Prostate Carcinoma
- ADT combined with abiraterone
- neoadjuvant hormone and RT
-
Hefei, Anhui, China
- +5 more
Jan 28, 2023
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma Trial in Los Angeles (drug,
Not yet recruiting
- Oligometastatic Prostate Carcinoma
- +3 more
- Lutetium Lu-177 PNT2002
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Aug 15, 2022
Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,
Recruiting
- Oligometastatic Prostate Carcinoma
- +2 more
- Placebo Administration
- +3 more
-
Decatur, Illinois
- +2 more
Aug 11, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston
Withdrawn
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Apalutamide
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 14, 2021